4th Annual Pharmaceutical Reimbursement And Market Access Conference, 27-28 August 2012, Philadelphia, PA

Date: Jul-18-2012This August in Philadelphia, PA, Q1 Productions follows on its previous success in pharmaceutical reimbursement and market access. Bringing together representatives from all perspectives, from government and private payers to pharma's most successful companies, this year's event looks deep into reimbursement structures and informed coverage strategies.

With impending healthcare reform, beyond its outcome, government, payers and consumers continue to put pressure on the pharmaceutical industry to lower costs. The industry must prepare for every eventuality, compiling and best presenting the most compelling cases for the reimbursement of their products. This year's Pharmaceutical Reimbursement and Market Access Conference looks into successfully navigating reimbursement structures through thorough evidence development motivated by coverage decision making processes. Key presentations will include a PPACA update - examining the current and future impact on reimbursement structures, clarifying implications of accountable care organizations on reimbursement strategies, a panel discussion on how private payers triangulate the pieces of the puzzle to make reimbursement decisions and the private payer perspective on specialty pharmaceuticals.

Formal as well as informal networking opportunities will be integrated into the conference agenda over the event's two days, as both are critical to success within the industry. Through a thoughtfully blended program including case studies, panel discussions and tracked, tailored sessions, the 4th Annual Pharmaceutical Reimbursement and Market Access Conference will once again provide all the resources and strategic insights reimbursement executives will need to succeed. For full details and/or registration, visit http://www.q1productions.com/RxReimb.

Presenting Organizations to include: Blue Cross Blue Shield of FL, Blue Cross Blue Shield of IL, Priority Health, Acorda Therapeutics, Abbott Laboratories, GfK Bridgehead , Celgene, Covington & Burling, Endo Pharmaceuticals, EpsteinBeckerGreen, Everett Laboratories, Express Scripts, Genentech, The Medicines Company, Novartis, Pfizer Inc, Pharmaceutical Council, Regeneron Pharmaceuticals, Shire, Takeda, Thrombogenics and Xcenda

Courtesy: Medical News Today Note: Any medical information available in this news section is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional.